Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer - Wikidata - awgldk - TriplyDB

Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer

Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer

http://www.wikidata.org/entity/Q28245608

about

Wnt signaling pathways in urological cancers: past decades and still growing Secreted Frizzled-related protein-1 is a negative regulator of androgen receptor activity in prostate cancer The Wnt antagonist sFRP1 is downregulated in premalignant large bowel adenomas The Wnt-dependent signaling pathways as target in oncology drug discovery Tumor Suppressor Inactivation in the Pathogenesis of Adult T-Cell Leukemia Transcriptional silencing of secreted frizzled related protein 1 (SFRP 1) by promoter hypermethylation in non-small-cell lung cancer Down-regulation of SFRP1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinoma Genetic and epigenetic silencing of SCARA5 may contribute to human hepatocellular carcinoma by activating FAK signaling.Identification of methylated genes associated with aggressive bladder cancer.Examination of apoptosis signaling in pancreatic cancer by computational signal transduction analysis.Urothelial carcinoma: stem cells on the edge.The transcripts of SFRP1,CEP63 and EIF4G2 genes are frequently downregulated in transitional cell carcinomas of the bladder.Use of integrative epigenetic and cytogenetic analyses to identify novel tumor-suppressor genes in malignant melanoma The Wnt antagonist sFRP1 as a favorable prognosticator in human biliary tract carcinoma.Loss of MTUS1/ATIP expression is associated with adverse outcome in advanced bladder carcinomas: data from a retrospective study.Diagnostic value of SFRP1 as a favorable predictive and prognostic biomarker in patients with prostate cancer.Apoptosis associated with Wnt/β-catenin pathway leads to steroid-induced avascular necrosis of femoral head.CEBPD amplification and overexpression in urothelial carcinoma: a driver of tumor metastasis indicating adverse prognosis.Epigenetics of kidney cancer and bladder cancer.Bladder cancer: a simple model becomes complex.High Dickkopf-1 expression is associated with poor prognosis in patients with advanced urothelial carcinoma.Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?Genetic alterations in urothelial bladder carcinoma: an updated review.Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer.Fibroblast growth factor receptor 3 mutations in bladder tumors correlate with low frequency of chromosome alterations.Expression and prognostic value of SFRP1 and β-catenin in patients with glioblastoma Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer.Secreted Frizzled-related protein 1 (sFRP1) regulates spermatid adhesion in the testis via dephosphorylation of focal adhesion kinase and the nectin-3 adhesion protein complex.Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays.Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer.Role of two single nucleotide polymorphisms in secreted frizzled related protein 1 and bladder cancer risk.Bladder cancer subtypes defined by genomic alterations.Tissue microarray studies in bladder cancer.MiRNA-34 intrinsically links p53 tumor suppressor and Wnt signaling.Wnt signaling in castration-resistant prostate cancer: implications for therapy.Methylation markers for urine-based detection of bladder cancer: the next generation of urinary markers for diagnosis and surveillance of bladder cancer.Prognostic and predictive biomarkers in prostate cancer.Functional analyses and prognostic significance of SFRP1 expression in bladder cancer.LY6K is a novel molecular target in bladder cancer on basis of integrate genome-wide profiling.WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells.

P2860

Q21245761-37321199-50CC-4A3B-9523-4DA5CD7B5FA0 Q24319970-3D0F7D64-61D1-411D-9E98-A977A5EFB7CA Q24651437-042F0E47-C6BC-4BF6-AC28-AD281A1D84B5 Q24652979-389D0CF0-A960-4C1C-8FCF-535AE0AA791F Q28081287-3A6DA7E2-B9CE-4FCD-8AB4-341D821E4E66 Q28260824-00B50A02-57DF-457B-88BD-85A950F6EC83 Q33290638-42B183D1-3C05-4573-8865-2412CEAF69CF Q33559593-0C5383F2-4EF2-4659-9ABF-8F4FC3473970 Q33680247-52D56846-A7A9-4A62-8772-C98D2FCACA79 Q33680539-3776545E-9CFE-46B5-BEAE-75691CD5EA8B Q34092411-8AAC945F-285A-4BB1-BFF6-6C046FD1382C Q34484329-F76FE1DC-BA07-43C4-9242-444AC989E59E Q35091482-50BDE651-5766-4CC0-A06A-2CA9B1D3DA6C Q35110848-23DA23EC-22AE-49F3-8580-896C3C5F8EC2 Q35125879-2068EB03-A032-47C6-BBED-3A75C79B6D1D Q35568239-EE72C382-39D9-4655-8771-3CD8D348B30A Q35650335-9FBEFF0D-84CA-45F7-8F2E-A0788946E80E Q35755517-E1E6E1CF-4D69-4027-AA0F-29076AAF1AF1 Q35857807-2F3890E2-BE70-4781-A171-2EBFF05C20FE Q36108115-9C3D27C0-29E9-4C31-8EDA-37AF2461CC81 Q36244287-09BF695C-F174-4EC2-8B99-8E19607496DF Q36341182-2503747E-9F39-4F48-AA12-634B4145A60F Q36393012-8ECC138F-2122-4DB8-9456-5D0C4A74C9E3 Q36395100-99A51EEB-8C8C-47BF-8383-2615EB31BEE2 Q36405463-2A864521-338D-4F7C-8AE1-07D459A9E1C6 Q36502673-AB63F3B7-CE32-4B64-817D-4AD91F1A48F5 Q36510089-8E534620-3616-4A3B-98FF-A91ACBBD6DEB Q36534407-F33D1579-3FF5-431E-8DBA-C743796E9633 Q36614678-7011F19D-E654-488E-A516-271C9072B408 Q37227743-33F5D173-39F2-4FCE-9D36-848FF6D0AA9D Q37228792-FD2A3DA3-0B6D-4D3D-8FAF-71459575FA05 Q37278990-7EBF5CFD-A12D-41ED-BFD9-EED4C8F45ABB Q37278995-9E574122-0E1E-4AFA-9C08-3A74713E2654 Q37993984-8B710BF2-C0A4-43CD-9796-99EFE5D8DE06 Q38241850-B471543D-ADEF-4464-B10F-9AF364574A70 Q38566949-72606AD0-9341-4597-97AA-5F9135C657F4 Q38628081-F487A193-7D9C-4CC7-A273-2315E4E29D79 Q38904558-C705D28E-6B3B-4319-B910-EE05FFFBF02C Q39633864-59E68BCF-7EE4-49CD-AA93-CFF3AAB9922F Q39890176-C3589215-31EE-4F99-8F71-8D5D724A3468

P2860

Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer

http://www.wikidata.org/entity/Q28245608

description

2004 nî lūn-bûn

@nan

2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Deletions of chromosome 8p and ...... rs of papillary bladder cancer

@ast

Deletions of chromosome 8p and ...... rs of papillary bladder cancer

@en

Deletions of chromosome 8p and ...... rs of papillary bladder cancer

@nl

type

label

Deletions of chromosome 8p and ...... rs of papillary bladder cancer

@ast

Deletions of chromosome 8p and ...... rs of papillary bladder cancer

@en

Deletions of chromosome 8p and ...... rs of papillary bladder cancer

@nl

prefLabel

Deletions of chromosome 8p and ...... rs of papillary bladder cancer

@ast

Deletions of chromosome 8p and ...... rs of papillary bladder cancer

@en

Deletions of chromosome 8p and ...... rs of papillary bladder cancer

@nl

P1433

Q28245608-6C1FB8A7-72E8-4676-B81B-0CA09AA5753D

P1476

Q28245608-D521A04C-3B2B-4576-ACD3-273528CA33B2

P2093

Q28245608-0CBA6F9D-660D-4D73-B394-E3E965CD9B4C

Q28245608-235CB4A4-F1C1-4213-8A59-DF719E226A7F

Q28245608-31CAA89B-6B40-4FD8-AE15-00CCC9FB3511

Q28245608-3D5D26DC-5D9A-497D-9D4F-84A967E73AEC

Q28245608-660ECAC1-9DCC-4585-BE6A-11677F65C688

Q28245608-76B3B2EC-561D-414B-BBA6-206385806FC5

Q28245608-934F444B-5C49-492A-A493-D4C124ADEC6F

Q28245608-A8D5AA30-D0F9-4529-8C9A-DBC23A42D5A7

Q28245608-BE133BDB-1B33-42EE-944F-E38955F53E41

Q28245608-C3F1D644-539B-4916-A20C-7A786512F387

P2860

Q28245608-05513AB7-7B28-4D33-8196-A04462E91083

Q28245608-0C029E21-EA0A-4729-8505-BFFEC245B73E

Q28245608-11CEFB7D-F38B-455C-B0D1-15A66C0FB211

Q28245608-3745E5BF-267A-4952-92A8-F0F5D58A50A5

Q28245608-43A28AFD-A979-4CB7-8999-BCE12A7F166E

Q28245608-4B1389DD-A18A-4116-BB03-6C4CCFC6666B

Q28245608-4FD25428-3C39-46E3-B537-34679046C78B

Q28245608-5A9C1F0E-7626-4F89-B193-19DE08B342E1

Q28245608-5AF0E183-5550-47A5-9913-C222775605EF

Q28245608-680C2486-6ABC-44BB-A7EF-B5DA5E07E347

P2888

Q28245608-24B86165-363F-46A1-B22F-E45EB831A703

P304

Q28245608-97D3F791-1AB9-4C01-88E8-7900C4148C2A

P31

Q28245608-F38CC600-831C-4260-B2AF-A0B057EC8C9A

P356

Q28245608-D9D06EF6-33CD-42F3-B345-A3DEB19C1C1D

P407

Q28245608-A568993C-8044-4F81-A6ED-BC6449DD3041

P433

Q28245608-2F102C63-D624-43C0-8FB8-BBD155C969E4

P478

Q28245608-726FB04D-827D-4127-9CF0-3C8D30D8814A

P50

Q28245608-4B965849-9402-40AB-8CDE-AFB7AEC20779

Q28245608-AF22A781-337C-4541-A93F-4FA88F286D10

Q28245608-C519839B-9F46-41A8-A622-509432DB0465

Q28245608-E61CF504-35EA-46F0-9F0F-2C6518609CE9

Q28245608-EE4B4C3A-A789-47C8-87C9-675FFDE94C85

P577

Q28245608-BBC7AC0D-111D-4B7F-BC35-0AE6E85AC41C

P5875

Q28245608-8EDD580B-5089-4F28-8605-0951A59341D4

P6179

Q28245608-D0BB762E-5816-4587-AC1A-D57FB0C2F9C2

P698

Q28245608-7A9E3C5E-A0B7-4BFC-B2EE-70B1B9CA7141

P356

LABINVEST.3700068

P1433

Laboratory Investigation

P1476

Deletions of chromosome 8p and ...... rs of papillary bladder cancer

@en

P2093

Andre Rosenthal

http://www.w3.org/2001/XMLSchema#string

Arndt Hartmann

http://www.w3.org/2001/XMLSchema#string

Christoph Wissmann

http://www.w3.org/2001/XMLSchema#string

Dirk Zaak

http://www.w3.org/2001/XMLSchema#string

Ferdinand Hofstaedter

http://www.w3.org/2001/XMLSchema#string

Guido Sauter

http://www.w3.org/2001/XMLSchema#string

Hagen Blaszyk

http://www.w3.org/2001/XMLSchema#string

Hiromu Suzuki

http://www.w3.org/2001/XMLSchema#string

Peter Wild

http://www.w3.org/2001/XMLSchema#string

Rene C Krieg

http://www.w3.org/2001/XMLSchema#string

P2860

Interaction of frizzled related protein (FRP) with Wnt ligands and the frizzled receptor suggests alternative mechanisms for FRP inhibition of Wnt signaling

Loss of heterozygosity on 8p in prostate cancer implicates a role for dematin in tumor progression

Secreted frizzled-related protein-1 binds directly to Wingless and is a biphasic modulator of Wnt signaling

Up-regulation of human secreted frizzled homolog in apoptosis and its down-regulation in breast tumors

Identification of c-MYC as a target of the APC pathway

Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action

SARPs: a family of secreted apoptosis-related proteins

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

Regulation of LEF-1/TCF transcription factors by Wnt and other signals

WNT pathway and mammary carcinogenesis: loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type

P2888

labinvest.3700068

P304

465-78

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/LABINVEST.3700068

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P50

Ruth Knüchel-Clarke

Christian Pilarsky

P577

2004-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6573446

http://www.w3.org/2001/XMLSchema#string

P6179

1045951336

http://www.w3.org/2001/XMLSchema#string

P698

14968126

http://www.w3.org/2001/XMLSchema#string